Mucosal Tolerance: A Two-Edged Sword to Prevent and Treat Autoimmune Diseases (Q41621742)

5 October 2017

1 reference

title

Mucosal tolerance: a two-edged sword to prevent and treat autoimmune diseases (English)

1 reference

5 October 2017

Mucosal Tolerance: A Two-Edged Sword to Prevent and Treat Autoimmune Diseases (English)

1 reference

Crossref

https://api.crossref.org/works/10.1006/CLIN.1997.4432

21 November 2024

B. G. Xiao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9344693

21 November 2024

H. Link

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9344693

21 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9344693

21 November 2024

publication date

1 November 1997

1 reference

5 October 2017

November 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9344693

full work available at URL

21 November 2024

https://api.elsevier.com/content/article/PII:S0090122997944329?httpAccept=text/xml

1 reference

Crossref

https://api.crossref.org/works/10.1006/CLIN.1997.4432

https://api.elsevier.com/content/article/PII:S0090122997944329?httpAccept=text/plain

21 November 2024

1 reference

Crossref

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Clinical Immunology and Immunopathology

21 November 2024

published in

1 reference

5 October 2017

1 reference

5 October 2017

1 reference

5 October 2017

page(s)

119-128

1 reference

Mucosal immunology: new frontiers

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-gamma-expressing Th1-like cells and up-regulation of TGF-beta mRNA in mononuclear cells

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. V. Hierarchy of suppression by myelin basic protein from different species

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naive and primed adult mice--implications for autoimmunity

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Direct binding of autoimmune disease related T cell epitopes to purified Lewis rat MHC class II molecules

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Peptide competition for antigen presentation

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

TCR antagonism and T cell tolerance can be independently induced in a DR-restricted, hemagglutinin-specific T cell clone

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

T cell-mediated maintenance of natural self-tolerance: its breakdown as a possible cause of various autoimmune diseases

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Suppression of experimental autoimmune myasthenia gravis and experimental allergic encephalomyelitis by oral administration of acetylcholine receptor and myelin basic protein: double tolerance

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Immunoprophylaxis of atopy: light at the end of the tunnel?

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Antigen-driven bystander suppression after oral administration of antigens

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Interleukin-2 secreting cells in multiple sclerosis and controls

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Antigen‐driven tissue‐specific suppression following oral tolerance: Orally administered myelin basic protein suppresses proteolipid protein‐induced experimental autoimmune encephalomyelitis in the SJL mouse

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Peripheral tolerance of Th2 lymphocytes induced by continuous feeding of ovalbumin

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

B cell responses to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Induction of Interferon-γ, Interleukin-4, and Transforming Growth Factor-β in Rats Orally Tolerized against Experimental Autoimmune Myasthenia Gravis

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Cytokine-dependent Modulation of Oral Tolerance in a Murine Model of Autoimmune Uveitis

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Intranasal administration of retinal antigens suppresses retinal antigen-induced experimental autoimmune uveoretinitis

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Oral tolerance to insulin and the insulin B-chain: cell lines and cytokine patterns

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Oral insulin does not prevent insulin-dependent diabetes mellitus in BB rats

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Tolerance to an arthritogenic T-cell epitope of HSP65 and the regulation of experimental arthritis

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Arthritis: animal models of oral tolerance

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Antigen-specific TGF-beta1 secretion with bovine myelin oral tolerization in multiple sclerosis

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Complexities in the treatment of autoimmune disease

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Induction of Autoimmune Diabetes by Oral Administration of Autoantigen

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Oral tolerance in myasthenia gravis

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

Orally induced, peptide-specific gamma/delta TCR+ cells suppress experimental autoimmune uveitis

21 November 2024

1 reference

https://api.crossref.org/works/10.1006/CLIN.1997.4432

21 November 2024

Identifiers

1 reference

5 October 2017

1 reference